215
Participants
Start Date
March 31, 2011
Primary Completion Date
June 30, 2012
Study Completion Date
June 30, 2012
Aripiprazole
Tablets, Oral, 2-15 mg, once daily, 13-42 weeks
Placebo
Tablets, Oral, 0 mg, once daily, 16 weeks
Stony Brook University School Of Medicine, Stony Brook
Western Psychiatric Institute And Clinic, Pittsburgh
Drexel University College Of Medicine, Philadelphia
Children'S National Medical Center, Washington D.C.
Virginia Treatment Center For Children, Richmond
Childrens Specialty Gr., Pllc, Norfolk
Unc Chapel Hill, Chapel Hill
Institute For Behavioral Medicine, Llc, Smyrna
Sarkis Clinical Trials, Gainesville
Florida Clinical Research Center, Llc, Maitland
Palm Springs Research Institute, Hialeah
Miami Children'S Hospital, Miami
University Of South Florida, Tampa
Harmonex Neuroscience Research, Inc, Dothan
Holston Medical Group, Kingsport
Kosair Charities Pediatric Clinical Research Unit, Louisville
The Ohio State University Nisonger Center, Columbus
Cleveland Clinic, Cleveland
University Hospitals Case Medical Center, Cleveland
Neurobehavioral Medicine Group, Bloomfield Hills
Lsu Health Sciences Center, Shreveport
Cutting Edge Research Group, Oklahoma City
Ou Physician'S Child Study Center, Oklahoma City
Tulsa Clinical Research, Llc, Tulsa
Insite Clinical Research, DeSoto
Kootenai Behavioral Health Center, Coeur d'Alene
Ericksen Research And Development, Clinton
Southwest Autism Research And Resource Center, Phoenix
Center For Psychiatry And Behavioral Medicine, Inc, Las Vegas
Behavioral Research Specialists, Llc, Glendale
Clinical Innovations, Inc., Costa Mesa
Ucsf - Lppi, San Francisco
Stanford University School Of Medicine, Stanford
Abbey Neuropsychology Clinic, Palo Alto
Cyn3rgy Research, Gresham
Neurocare, Inc., Newton
Clinical Research Center Of New Jersey, Gibbsboro
Children'S Specialized Hosp, Toms River
Lead Sponsor
Bristol-Myers Squibb
INDUSTRY